Literature DB >> 23454193

Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders.

Silvia Zucchini1, Anna Pittaluga, Egidio Brocca-Cofano, Maria Summa, Marina Fabris, Rita De Michele, Angela Bonaccorsi, Graziella Busatto, Giuseppe Barbanti-Brodano, Giuseppe Altavilla, Gianluca Verlengia, Pierangelo Cifelli, Alfredo Corallini, Antonella Caputo, Michele Simonato.   

Abstract

HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenously produced Tat in the brain was investigated using a tat-transgenic (TT) mouse model constitutively expressing the HIV-1 tat gene. We found that stimulus-evoked glutamate exocytosis in the hippocampus and cortex was significantly increased in TT as compared with wild-type control (CC) mice, while GABA exocytosis was unchanged in the hippocampus and decreased in the cortex. This suggests that Tat generates a latent hyper-excitability state, which favors the detrimental effects of neurotoxic and/or excitotoxic agents. To challenge this idea, TT mice were tested for susceptibility to kainate-induced seizures and neurodegeneration, and found to exhibit significantly greater responses to the convulsant agent than CC mice. These results support the concept that constitutive expression of tat in the brain generates a latent excitatory state, which may increase the negative effects of damaging insults. These events may play a key role in the development of HAND.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23454193     DOI: 10.1016/j.nbd.2013.02.004

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  25 in total

1.  Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS.

Authors:  Douglas J Hermes; Changqing Xu; Justin L Poklis; Micah J Niphakis; Benjamin F Cravatt; Ken Mackie; Aron H Lichtman; Bogna M Ignatowska-Jankowska; Sylvia Fitting
Journal:  Neuropharmacology       Date:  2018-08-13       Impact factor: 5.250

2.  Immuno-Pharmacological Characterization of Presynaptic GluN3A-Containing NMDA Autoreceptors: Relevance to Anti-NMDA Receptor Autoimmune Diseases.

Authors:  Guendalina Olivero; Matteo Vergassola; Francesca Cisani; Cesare Usai; Anna Pittaluga
Journal:  Mol Neurobiol       Date:  2019-02-07       Impact factor: 5.590

Review 3.  Animal models for depression associated with HIV-1 infection.

Authors:  Isabella Cristina Gomes Barreto; Patricia Viegas; Edward B Ziff; Elisabete Castelon Konkiewitz
Journal:  J Neuroimmune Pharmacol       Date:  2013-12-12       Impact factor: 4.147

Review 4.  Targeting HIV transcription: the quest for a functional cure.

Authors:  Guillaume Mousseau; Sonia Mediouni; Susana T Valente
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

5.  SIV-Mediated Synaptic Dysfunction Is Associated with an Increase in Synapsin Site 1 Phosphorylation and Impaired PP2A Activity.

Authors:  Masoud Shekarabi; Jake A Robinson; Mandy D Smith; Tricia H Burdo
Journal:  J Neurosci       Date:  2019-07-03       Impact factor: 6.167

Review 6.  HIV, Tat and dopamine transmission.

Authors:  Peter J Gaskill; Douglas R Miller; Joyonna Gamble-George; Hideaki Yano; Habibeh Khoshbouei
Journal:  Neurobiol Dis       Date:  2017-04-27       Impact factor: 5.996

7.  HIV-1 Tat-induced changes in synaptically-driven network activity adapt during prolonged exposure.

Authors:  Kelly A Krogh; Matthew V Green; Stanley A Thayer
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

8.  Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters.

Authors:  Sylvia Fitting; Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2017-10-27       Impact factor: 2.457

9.  Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices.

Authors:  Changqing Xu; Douglas J Hermes; Ken Mackie; Aron H Lichtman; Bogna M Ignatowska-Jankowska; Sylvia Fitting
Journal:  J Neuroimmune Pharmacol       Date:  2016-03-18       Impact factor: 4.147

10.  Conditional Human Immunodeficiency Virus Transactivator of Transcription Protein Expression Induces Depression-like Effects and Oxidative Stress.

Authors:  Jay P McLaughlin; Jason J Paris; Dionyssios Mintzopoulos; Kristen A Hymel; Jae K Kim; Thomas J Cirino; Timothy E Gillis; Shainnel O Eans; Gordana D Vitaliano; Jessica M Medina; Richard C Krapf; Heather M Stacy; Marc J Kaufman
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.